• Tech
• Gadgets
• Mobile
• Enterprise
• CrunchBase
• More
  • Beta Invites
  • Elevator Pitches
  • Gillmor Gang
  • Podcasts
  • TechCrunch50
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Flexion Therapeutics

edit

lexion Therapeutics advances drug candidates through clinical proof of concept and beyond, in partnership with pharmaceutical and biotechnology companies. By providing expertise and sharing risk, Flexion effectively expands the portfolios of its partners.

Milestones

edit

• 
  Flexion Therapeutics received $33M in Series A funding. (10/09)
  Posted 10/19/09 at 5:56pm
• 
  Flexion Therapeutics added Mike Clayman as CEO.
  Posted 10/19/09 at 5:56pm
• 
  Flexion Therapeutics added Neil Bodick as COO.
  Posted 10/19/09 at 5:56pm

Videos

Screenshots

edit

Sources

1. Flexion garners $33M in Series A (fiercebiotech.com) [edit]